{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T07:49:12Z","timestamp":1781596152941,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T00:00:00Z","timestamp":1568851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T00:00:00Z","timestamp":1568851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19fk0210040"],"award-info":[{"award-number":["JP19fk0210040"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s00535-019-01626-1","type":"journal-article","created":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T11:03:47Z","timestamp":1568891027000},"page":"100-112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Diagnostic accuracy of combined biomarker measurements and vibration-controlled transient elastography (VCTE) for predicting fibrosis stage of non-alcoholic fatty liver disease"],"prefix":"10.1007","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4120-9121","authenticated-orcid":false,"given":"Toshihide","family":"Shima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohisa","family":"Oya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhide","family":"Mitsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kanbara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Okanoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,19]]},"reference":[{"key":"1626_CR1","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the study of liver diseases. Hepatology. 2018;67:328\u201357.","journal-title":"Hepatology"},{"issue":"389\u201397","key":"1626_CR2","first-page":"e10","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149(389\u201397):e10.","journal-title":"Gastroenterology"},{"key":"1626_CR3","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/hep.26156","volume":"57","author":"D Kim","year":"2013","unstructured":"Kim D, Kim WR, Kim HJ, et al. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology. 2013;57:1357\u201365.","journal-title":"Hepatology"},{"key":"1626_CR4","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/hep.29085","volume":"65","author":"PS Dulai","year":"2017","unstructured":"Dulai PS, Singh S, Patel J, et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis. Hepatology. 2017;65:1557\u201365.","journal-title":"Hepatology"},{"key":"1626_CR5","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/hep.28226","volume":"63","author":"K Yoshimura","year":"2016","unstructured":"Yoshimura K, Okanoue T, Ebise H, et al. Identification of novel noninvasive markers for diagnosing nonalcoholic steatohepatitis and related fibrosis by data mining. Hepatology. 2016;63:462\u201373.","journal-title":"Hepatology"},{"key":"1626_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00535-017-1355-9","volume":"53","author":"T Okanoue","year":"2018","unstructured":"Okanoue T, Ebise H, Kai T, et al. A simple scoring system using type IV collagen 7s and aspartate aminotransferase for diagnosing nonalcoholic steatohepatitis and related fibrosis. J Gastroenterol. 2018;53:129\u201339.","journal-title":"J Gastroenterol"},{"key":"1626_CR7","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/apt.12569","volume":"39","author":"R Kwok","year":"2014","unstructured":"Kwok R, Tse YK, Wong GL, et al. Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease\u2014the role of transient elastography and plasma cytokeratin-18 fragments. Aliment Pharmacol Ther. 2014;39:254\u201369.","journal-title":"Aliment Pharmacol Ther"},{"key":"1626_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00535-017-1414-2","volume":"53","author":"M Yoneda","year":"2018","unstructured":"Yoneda M, Imajo K, Takahashi H, et al. Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods. J Gastroenterol. 2018;53:181\u201396.","journal-title":"J Gastroenterol"},{"key":"1626_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/hep.29721","volume":"68","author":"ZM Younossi","year":"2018","unstructured":"Younossi ZM, Loomba R, Anstee QM, et al. Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis. Hepatology. 2018;68:349\u201360.","journal-title":"Hepatology"},{"key":"1626_CR10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jhep.2017.11.013","volume":"68","author":"E Vilar-Gomez","year":"2018","unstructured":"Vilar-Gomez E, Chalasani N. Non-invasive assessment of non-alcoholic fatty liver disease: clinical prediction rules and blood-based biomarkers. J Hepatol. 2018;68:305\u201315.","journal-title":"J Hepatol"},{"key":"1626_CR11","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313\u201321.","journal-title":"Hepatology"},{"key":"1626_CR12","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","volume":"116","author":"CA Matteoni","year":"1999","unstructured":"Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413\u20139.","journal-title":"Gastroenterology"},{"key":"1626_CR13","first-page":"477","volume":"101","author":"FC Kruger","year":"2011","unstructured":"Kruger FC, Daniels CR, Kidd M, et al. Apri: a simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with Nafld\/Nash. S Afr Med J. 2011;101:477\u201380.","journal-title":"S Afr Med J"},{"key":"1626_CR14","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","volume":"7","author":"AG Shah","year":"2009","unstructured":"Shah AG, Lydecker A, Murray K, et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009;7:1104\u201312.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1626_CR15","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo P, Hui JM, Marchesini G, et al. The Nafld fibrosis score: a noninvasive system that identifies liver fibrosis in patients with Nafld. Hepatology. 2007;45:846\u201354.","journal-title":"Hepatology"},{"key":"1626_CR16","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018Ezr\u2019 for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"1626_CR17","unstructured":"Kanda Y. Free Statistical Software: Ezr (Easy R) on R Commander."},{"key":"1626_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","volume":"143","author":"JA Hanley","year":"1982","unstructured":"Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (Roc) curve. Radiology. 1982;143:29\u201336.","journal-title":"Radiology"},{"key":"1626_CR19","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837\u201345.","journal-title":"Biometrics"},{"key":"1626_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/sim.2929","volume":"27","author":"MJ Pencina","year":"2008","unstructured":"Pencina MJ, D\u2019Agostino RB Sr, D\u2019Agostino RB Jr, et al. Evaluating the added predictive ability of a new marker: from area under the roc curve to reclassification and beyond. Stat Med. 2008;27:157\u201372 (discussion 207\u2013212).","journal-title":"Stat Med."},{"key":"1626_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/sim.4085","volume":"30","author":"MJ Pencina","year":"2011","unstructured":"Pencina MJ, D\u2019Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30:11\u201321.","journal-title":"Stat Med"},{"key":"1626_CR22","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/hep.25993","volume":"57","author":"J Boursier","year":"2013","unstructured":"Boursier J, Zarski JP, de Ledinghen V, et al. Determination of reliability criteria for liver stiffness evaluation by transient elastography. Hepatology. 2013;57:1182\u201391.","journal-title":"Hepatology"},{"key":"1626_CR23","first-page":"e16","volume":"38","author":"CF Dietrich","year":"2017","unstructured":"Dietrich CF, Bamber J, Berzigotti A, et al. Efsumb guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (long version). Ultraschall Med. 2017;38:e16\u201347.","journal-title":"Ultraschall Med"},{"key":"1626_CR24","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1053\/j.gastro.2017.03.016","volume":"152","author":"S Singh","year":"2017","unstructured":"Singh S, Muir AJ, Dieterich DT, et al. American gastroenterological association institute technical review on the role of elastography in chronic liver diseases. Gastroenterology. 2017;152:1544\u201377.","journal-title":"Gastroenterology"},{"key":"1626_CR25","first-page":"828","volume":"51","author":"L Castera","year":"2010","unstructured":"Castera L, Foucher J, Bernard PH, et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology. 2010;51:828\u201335.","journal-title":"Hepatology"},{"key":"1626_CR26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","volume":"63","author":"European Association for Study of L, Asociacion Latinoamericana para el Estudio del H","year":"2015","unstructured":"European Association for Study of L, Asociacion Latinoamericana para el Estudio del H. Easl-Aleh clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63:237\u201364.","journal-title":"J Hepatol."},{"key":"1626_CR27","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","volume":"29","author":"L Sandrin","year":"2003","unstructured":"Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29:1705\u201313.","journal-title":"Ultrasound Med Biol"},{"key":"1626_CR28","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/hep.22007","volume":"47","author":"U Arena","year":"2008","unstructured":"Arena U, Vizzutti F, Corti G, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology. 2008;47:380\u20134.","journal-title":"Hepatology"},{"key":"1626_CR29","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1002\/hep.22577","volume":"48","author":"G Millonig","year":"2008","unstructured":"Millonig G, Reimann FM, Friedrich S, et al. Extrahepatic cholestasis increases liver stiffness (Fibroscan) irrespective of fibrosis. Hepatology. 2008;48:1718\u201323.","journal-title":"Hepatology"},{"key":"1626_CR30","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/hep.29302","volume":"66","author":"G Xiao","year":"2017","unstructured":"Xiao G, Zhu S, Xiao X, et al. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis. Hepatology. 2017;66:1486\u2013501.","journal-title":"Hepatology"},{"key":"1626_CR31","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/hepr.12388","volume":"45","author":"K Yoshioka","year":"2015","unstructured":"Yoshioka K, Hashimoto S, Kawabe N. Measurement of liver stiffness as a non-invasive method for diagnosis of non-alcoholic fatty liver disease. Hepatol Res. 2015;45:142\u201351.","journal-title":"Hepatol Res."},{"key":"1626_CR32","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/hep.21984","volume":"47","author":"IN Guha","year":"2008","unstructured":"Guha IN, Parkes J, Roderick P, et al. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European liver fibrosis panel and exploring simple markers. Hepatology. 2008;47:455\u201360.","journal-title":"Hepatology"},{"key":"1626_CR33","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1053\/j.gastro.2004.08.052","volume":"127","author":"WM Rosenberg","year":"2004","unstructured":"Rosenberg WM, Voelker M, Thiel R, et al. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology. 2004;127:1704\u201313.","journal-title":"Gastroenterology"},{"key":"1626_CR34","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1148\/radiol.2016160685","volume":"283","author":"J Chen","year":"2017","unstructured":"Chen J, Yin M, Talwalkar JA, et al. Diagnostic performance of Mr elastography and vibration-controlled transient elastography in the detection of hepatic fibrosis in patients with severe to morbid obesity. Radiology. 2017;283:418\u201328.","journal-title":"Radiology"},{"key":"1626_CR35","unstructured":"Hsu C, Caussy C, Imajo K, et al. Magnetic resonance vs transient elastography analysis of patients with nonalcoholic fatty liver disease: a systematic review and pooled analysis of individual participants. Clin Gastroenterol Hepatol. 2018."},{"key":"1626_CR36","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/hep.28337","volume":"63","author":"J Cui","year":"2016","unstructured":"Cui J, Heba E, Hernandez C, et al. Magnetic resonance elastography is superior to acoustic radiation force impulse for the diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: a prospective study. Hepatology. 2016;63:453\u201361.","journal-title":"Hepatology"},{"issue":"626\u201337","key":"1626_CR37","first-page":"e7","volume":"150","author":"K Imajo","year":"2016","unstructured":"Imajo K, Kessoku T, Honda Y, et al. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology. 2016;150(626\u201337):e7.","journal-title":"Gastroenterology"},{"issue":"598\u2013607","key":"1626_CR38","first-page":"e2","volume":"152","author":"CC Park","year":"2017","unstructured":"Park CC, Nguyen P, Hernandez C, et al. Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease. Gastroenterology. 2017;152(598\u2013607):e2.","journal-title":"Gastroenterology"},{"key":"1626_CR39","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1111\/liv.12584","volume":"35","author":"S Petta","year":"2015","unstructured":"Petta S, Vanni E, Bugianesi E, et al. The combination of liver stiffness measurement and Nafld fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease. Liver Int. 2015;35:1566\u201373.","journal-title":"Liver Int."},{"key":"1626_CR40","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1111\/j.1478-3231.2009.02101.x","volume":"29","author":"J Boursier","year":"2009","unstructured":"Boursier J, Vergniol J, Sawadogo A, et al. The combination of a blood test and fibroscan improves the non-invasive diagnosis of liver fibrosis. Liver Int. 2009;29:1507\u201315.","journal-title":"Liver Int."},{"key":"1626_CR41","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/MCG.0000000000000788","volume":"51","author":"A Ducancelle","year":"2017","unstructured":"Ducancelle A, Leroy V, Vergniol J, et al. A single test combining blood markers and elastography is more accurate than other fibrosis tests in the main causes of chronic liver diseases. J Clin Gastroenterol. 2017;51:639\u201349.","journal-title":"J Clin Gastroenterol"},{"key":"1626_CR42","doi-asserted-by":"publisher","first-page":"190","DOI":"10.5009\/gnl17092","volume":"12","author":"JY Heo","year":"2018","unstructured":"Heo JY, Kim BK, Park JY, et al. Combination of transient elastography and an enhanced liver fibrosis test to assess the degree of liver fibrosis in patients with chronic hepatitis B. Gut Liver. 2018;12:190\u2013200.","journal-title":"Gut Liver."},{"key":"1626_CR43","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/ajg.2011.100","volume":"106","author":"J Boursier","year":"2011","unstructured":"Boursier J, de Ledinghen V, Zarski JP, et al. A new combination of blood test and fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C. Am J Gastroenterol. 2011;106:1255\u201363.","journal-title":"Am J Gastroenterol"},{"key":"1626_CR44","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/liv.12327","volume":"34","author":"P Cales","year":"2014","unstructured":"Cales P, Boursier J, Ducancelle A, et al. Improved fibrosis staging by elastometry and blood test in chronic hepatitis C. Liver Int. 2014;34:907\u201317.","journal-title":"Liver Int."},{"key":"1626_CR45","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1111\/liv.13440","volume":"37","author":"CS Voican","year":"2017","unstructured":"Voican CS, Louvet A, Trabut JB, et al. Transient elastography alone and in combination with Fibrotest((R)) for the diagnosis of hepatic fibrosis in alcoholic liver disease. Liver Int. 2017;37:1697\u2013705.","journal-title":"Liver Int."},{"key":"1626_CR46","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1097\/MEG.0000000000000409","volume":"27","author":"E Dincses","year":"2015","unstructured":"Dincses E, Yilmaz Y. Diagnostic usefulness of fibrometer Vcte for hepatic fibrosis in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2015;27:1149\u201353.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1626_CR47","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1111\/jgh.13671","volume":"32","author":"TC Loong","year":"2017","unstructured":"Loong TC, Wei JL, Leung JC, et al. Application of the combined fibrometer vibration-controlled transient elastography algorithm in chinese patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2017;32:1363\u20139.","journal-title":"J Gastroenterol Hepatol"},{"key":"1626_CR48","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/hep.24624","volume":"55","author":"RP Myers","year":"2012","unstructured":"Myers RP, Pomier-Layrargues G, Kirsch R, et al. Feasibility and diagnostic performance of the Fibroscan Xl probe for liver stiffness measurement in overweight and obese patients. Hepatology. 2012;55:199\u2013208.","journal-title":"Hepatology"},{"key":"1626_CR49","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.jhep.2011.10.017","volume":"56","author":"V de Ledinghen","year":"2012","unstructured":"de Ledinghen V, Wong VW, Vergniol J, et al. Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and Xl probe of Fibroscan(R). J Hepatol. 2012;56:833\u20139.","journal-title":"J Hepatol"},{"key":"1626_CR50","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/hep.29489","volume":"67","author":"R Vuppalanchi","year":"2018","unstructured":"Vuppalanchi R, Siddiqui MS, Van Natta ML, et al. Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease. Hepatology. 2018;67:134\u201344.","journal-title":"Hepatology"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-019-01626-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-019-01626-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-019-01626-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T16:11:25Z","timestamp":1650471085000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-019-01626-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,19]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["1626"],"URL":"https:\/\/doi.org\/10.1007\/s00535-019-01626-1","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,19]]},"assertion":[{"value":"23 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"T. Shima has received research funding from Bristol-Myers Squibb. All authors have no conflicts of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}